What Is a Normal Nuchal Translucency Measurement at 13 Weeks?

At 13 weeks of gestation, a typical nuchal translucency measurement falls somewhere around 2 to 2.3 mm, with most practitioners treating anything under about 3.0 mm as reassuring. But the “normal” range is not a single fixed number. NT naturally increases as the fetus grows, and whether a result is considered elevated depends on how the measurement is interpreted relative to gestational age or fetal size.

What Nuchal Translucency Actually Is

Nuchal translucency refers to a temporary pocket of fluid that collects in the soft tissue at the back of a fetus’s neck during early pregnancy. It shows up as a dark, translucent strip on ultrasound, which is where the name comes from. This fluid accumulation is present in every fetus to some degree. It is measured during a narrow window, typically between 11 weeks and 13 weeks plus 6 days of gestation.¹

Why the fluid collects there in the first place is not entirely settled. Researchers have identified several contributing mechanisms: temporary cardiac strain that causes fluid backup, differences in the structure of the skin and connective tissue at the nape of the neck, and early lymphatic drainage systems that have not yet fully developed.² In most pregnancies, the fluid is modest and clears on its own as the lymphatic system matures. When the pocket is unusually thick, it can signal problems with chromosomes, the heart, or other developing structures.

How Much the Measurement Changes Between 11 and 14 Weeks

One of the most important things to understand about NT is that it grows along with the fetus. A measurement that would be perfectly normal at 13 weeks might be on the high side at 11 weeks, and vice versa. One study tracking NT across early pregnancy found the median thickness was about 1.95 mm at 11 weeks, rose to 2.3 mm at 12 weeks, dipped slightly to 2.25 mm at 13 weeks, and then climbed to 2.5 mm at 14 weeks.³ These are medians for healthy pregnancies, meaning half of normal fetuses measured above and half below.

Because NT changes with fetal size, clinicians do not simply compare your measurement to a flat cutoff. Instead, the measurement is usually interpreted against the fetus’s crown-rump length, which is the head-to-bottom measurement used to estimate gestational age in early pregnancy. Reference charts plot the expected range of NT for each crown-rump length.⁴ A large multicenter study in Thailand, for instance, derived a formula for the 95th percentile of NT at various fetal sizes using quantile regression modeling.⁵ The point is that “normal” is a moving target that depends on how big the baby is at the time of scanning.

Where the Line Between Normal and Elevated Falls

There is no universally agreed-upon single cutoff for what counts as an elevated NT. Different screening programs use different thresholds, and the choice involves trade-offs between catching more affected pregnancies and flagging more healthy ones for further testing.

The most commonly used fixed cutoff is 3.0 mm. Any measurement at or above that level is generally considered increased, regardless of gestational age. Some programs use 3.5 mm for certain purposes. A newer approach uses multiples of the median (MoM), where your NT is compared to the median for fetuses of the same crown-rump length. A threshold of 1.9 MoM, for example, approximates the 99th percentile and has been shown to have better specificity than a flat 3.0 mm cutoff.⁶ In practical terms, this means that at 13 weeks a measurement of, say, 2.5 mm would generally be considered normal, while 3.2 mm would raise a flag in most screening programs.

One important nuance: a measurement right at or slightly above the cutoff carries very different implications than one that is dramatically elevated. A reading of 3.1 mm is a very different situation from one of 6 mm. The risk of serious problems climbs steeply with the size of the measurement, and clinicians factor in the degree of elevation rather than treating the cutoff as a simple pass/fail line.

What an Increased NT Can Signal About Chromosomes

The primary reason NT screening exists is its association with chromosomal abnormalities, most famously Down syndrome (trisomy 21). A landmark study in the New England Journal of Medicine found that among fetuses showing nuchal translucency or cystic hygroma, about a quarter had an abnormal karyotype. The sensitivity for trisomies 21, 18, and 13 combined was around 62 percent, and for trisomy 21 alone it was about 54 percent.⁷

A large Lancet study that combined NT thickness with maternal age showed that looking at just the 5 percent of pregnancies with the highest estimated risk captured roughly 77 percent of trisomy 21 cases.⁸ That is impressive for a single ultrasound measurement, though it also means some affected pregnancies are missed.

The degree of NT elevation matters. Research has found that most fetuses with trisomy 21 had NT measurements below 4.5 mm, while fetuses with trisomies 13 or 18 tended to have thicker measurements in the 4.5 to 8.4 mm range, and those with Turner syndrome often exceeded 8.5 mm.⁹ So a very high measurement raises concern for different conditions than a moderately elevated one.

Heart Defects and Conditions Beyond Chromosomes

An elevated NT is not only about chromosomal problems. Even when the chromosomes are completely normal, a thicker-than-expected measurement has been linked to congenital heart defects. A pooled analysis from major fetal echocardiography centers found that among chromosomally normal fetuses with heart defects, close to 23 percent had an NT of 3.5 mm or greater.¹⁰ NT performs more modestly as a screening tool for heart defects than for chromosomal conditions, but the association is well established.¹¹

The connection between NT and heart defects makes biological sense. Abnormal lymphatic development, which is the likely cause of the neck swelling, is closely related to early cardiac development.¹²

Another condition to be aware of is Noonan syndrome, a genetic disorder that affects growth, heart development, and facial features. Among fetuses with normal chromosomes but elevated NT, the risk of Noonan syndrome is estimated at around 10 percent.¹³ This is part of a broader group of conditions called RASopathies, which are increasingly being included in the workup when NT is elevated but standard chromosome testing comes back normal.¹⁴

Why Measurement Technique Matters So Much

NT measurement is one of the more technically demanding things asked of an ultrasound. The difference between a normal and elevated result can be fractions of a millimeter, so small errors in technique can genuinely change the interpretation.

Research has confirmed that both the period of gestation and the position of the fetal neck at the time of scanning make a meaningful difference. When the fetus has its neck flexed (chin tucked) or extended (head tilted back), the measurement can change compared to the neutral position. Repeatability is best when the neck is neutral.¹⁵

This is why NT screening is typically performed by sonographers who have been specifically trained and credentialed for it. Quality-assurance programs, such as those run by the Fetal Medicine Foundation, set strict criteria for how the measurement should be taken, including the fetal position, the magnification of the image, and the placement of the calipers.¹⁶ If you receive an NT measurement that seems borderline or unexpectedly high, it is reasonable to ask about the credentialing of the person who performed the scan and whether the image met the standard criteria.

NT as Part of Combined First-Trimester Screening

NT is rarely interpreted in isolation. In standard first-trimester screening, the NT measurement is combined with two blood markers drawn from the mother: PAPP-A and free beta-hCG. These three factors, along with maternal age, are fed into a risk calculation that produces a personalized probability for conditions like trisomy 21.¹⁷

The combined approach performs substantially better than any single component alone. Studies consistently show that including all three parameters produces the best test performance.¹⁸ The combined screen is also effective at detecting conditions beyond the common trisomies, including unbalanced chromosomal rearrangements that would otherwise be missed by standard testing.¹⁹

So if your NT measurement at 13 weeks comes back at, say, 1.8 mm, that number alone does not give you a final risk figure. It gets plugged into a calculation alongside your blood results and your age, and the combined output is what your provider uses for counseling.

Where Cell-Free DNA Screening Fits In

Cell-free DNA testing (sometimes called NIPT) analyzes fragments of fetal DNA circulating in the mother’s blood and is highly accurate for the common trisomies. Its arrival has raised a fair question: is NT measurement still necessary?

The answer is nuanced. For detecting trisomies 21, 18, and 13, cell-free DNA screening is more accurate than any standard screening that includes NT.²⁰ However, NT measurement picks up things that cell-free DNA does not: heart defects, Noonan syndrome, and other structural or genetic conditions that do not show up in the fetal DNA fragments in the mother’s blood. That said, a recent study found that NT was actually a poor discriminator for identifying the specific chromosome abnormalities missed by genome-wide cell-free DNA screening, with at least 90 percent of those undetected cases having an NT below any commonly used threshold.²¹

From a cost-effectiveness perspective, performing an ultrasound (including NT measurement) before cell-free DNA screening appears to be the most cost-effective approach compared to cell-free DNA alone. One analysis found the ultrasound-first strategy was slightly more costly but more effective, with the added benefit outweighing the added cost.²² A systematic review of economic evaluations concluded that using cell-free DNA as a first-line test for everyone was not cost-effective in most analyses, while a contingent approach that uses traditional screening first and reserves cell-free DNA for higher-risk pregnancies offered the best value.²³

In practice, many programs now use a layered approach. The first-trimester ultrasound with NT measurement serves as a broad-spectrum scan that also confirms dating, detects twins, and assesses basic anatomy. Cell-free DNA may then be offered based on the results or as a routine addition, depending on local guidelines and coverage.

What Happens After an Elevated Result

Getting told your NT measurement is elevated can be alarming. It helps to know what the follow-up pathway typically looks like, and that an elevated NT alone does not diagnose anything.

When NT is increased, best-practice guidelines recommend additional early scans around 14 to 18 weeks of gestation. These scans assess both cardiac and non-cardiac anatomy in detail to look for structural problems well before the routine mid-pregnancy scan that usually happens around 20 weeks.²⁴ Depending on the situation, further genetic testing such as chorionic villus sampling or amniocentesis may also be discussed. The availability of chromosomal microarray analysis has led to a resurgence in diagnostic testing rates after an elevated NT, reversing a brief dip that occurred when cell-free DNA screening initially led some patients to decline invasive procedures.²⁵

A typical management plan includes follow-up scans at around 14 to 16 weeks and again at 20 to 22 weeks, along with specialist fetal echocardiography and, in selected cases, infection screening and additional genetic testing.²⁶

Long-Term Outlook When Chromosomes and Scans Are Normal

Perhaps the most reassuring piece of evidence for parents who receive an elevated NT result is what happens when everything else checks out. A systematic review of neurodevelopmental outcomes found that among children with an elevated fetal NT, normal chromosomes, normal anatomy, and no identifiable genetic syndromes, the rate of developmental delay was no higher than in the general population.²⁷ A separate study offered similar guidance: when the chromosomes are normal and no structural problems are found after the NT resolves, the prognosis is positive.²⁸

That said, the picture is not quite as clean as “all clear.” One longer-term follow-up study tracked children born after elevated NT with normal chromosomes and a normal second-trimester anatomy scan. Over an average follow-up of about six and a half years, roughly 7 percent had some major health issue detected, including structural defects, genetic disorders, and minor anomalies that had not been identified prenatally.²⁹ That is higher than you would expect in the general population, and it suggests that an elevated NT, even with normal initial testing, deserves ongoing attention from pediatricians. Still, the large majority of these children did well.

The Emotional Side of a Screening Result

Screening tests are designed to catch problems early, but they can also generate significant anxiety, especially when results are positive. Research on maternal anxiety around NT screening found that women who received a positive result reported greater psychological distress immediately after getting the full report. The encouraging finding, though, was that anxiety levels between the groups equalized by 22 weeks of pregnancy and after delivery. Both women with normal and positive results remained strongly positive about having had the screening, both for the current pregnancy and for future ones.³⁰

If you find yourself anxiously Googling NT measurements at midnight, this is worth remembering. The distress of a flagged result is real but tends to be temporary, and most women valued the information even when it was initially stressful.

Twin Pregnancies and NT

NT screening in twin pregnancies adds another layer of complexity. The measurement is taken for each twin individually, but interpretation depends on whether the twins share a placenta (monochorionic) or have separate placentas (dichorionic). Research comparing outcomes in twins with elevated NT found that monochorionic twins with an increased measurement had a higher rate of structural anomalies and twin-specific complications than dichorionic twins with the same finding.³¹ This makes sense given that monochorionic twins face additional risks like twin-to-twin transfusion syndrome, which involves unequal blood flow between the shared placenta and can cause fluid imbalances. If you are carrying twins and one or both have an elevated NT, the type of twinning matters significantly for how the result is interpreted and managed.